Azenta, Inc.
NASDAQ:AZTAMedical - Instruments & Supplies
-$0.03 today
- Market cap
- $2.13B
- Beta
- 1.40
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$3.87
Volume 0.69M
Average 1.16M
AZTA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Azenta, Inc.NASDAQ: AZTA
EBITDA · Q4 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q4 FY2026 EBITDA of $22.84M rose 10.2% year over year, ahead of the -265.1% change in trailing-twelve-month EBITDA. Sequentially, it rose 58.3% from the prior quarter.
Context
- EBITDA amounted to 24.3% of revenue in FY2026, up 15.2 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $84.87M (+156.2%) for the fiscal year ending Sep 2027, a step up from the -379.3% reported in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $22.84M+58.3% QoQ
- Last fiscal yearSep 2026
- -$151.01M-379.3% YoY
- LTMSep 2026
- -$94.49M-265.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +10.2% | +134.6% | +124.4 pp |
| 1 year | -379.3% | +156.2% | +535.5 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2026
- (151.01M) USD
- Year-over-year change
- -379.3%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2026 | 2026-09-30 | (151.01M) | -379.3% |
| FY2025 | 2025-09-30 | 54.07M | -24.5% |
| FY2024 | 2024-09-30 | 71.62M | +29.9% |
| FY2023 | 2023-09-30 | 55.15M | +14.1% |
| FY2022 | 2022-09-30 | 48.36M | — |
EBITDA vs competitors
How AZTA compares with its peers on the latest reported figures
- AZTA's LTM Sep 2026 EBITDA of -$94.49M is the lowest of the 10 companies compared; the peer median is $328.77M.
- Its year-over-year change of -265.1% is the lowest of 10, against a peer median of +3.2%.
- EBITDA amounts to 15.2% of revenue for AZTA, versus a peer median of 19.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $11.24B | -0.8% | -1.3% | 23.7% | |
| LTM Sep 2026 | $7.09B | +3.2% | -9.9% | 27.7% | |
| LTM Jun 2026 | $2.47B | +93.4% | +3.9% | 29.7% | |
| LTM Jun 2026 | $514.7M | -22.7% | — | 19.9% | |
| LTM Sep 2026 | $328.77M | +48.3% | -9.1% | 26.8% | |
| LTM Jun 2026 | $247.7M | -38.6% | -16.4% | 7.1% | |
| LTM Aug 2026 | $105.13M | +112.0% | +9.9% | 11.9% | |
| LTM Mar 2026 | $43.38M | +4.0% | -2.0% | 17.4% | |
| LTM Mar 2026 | -$7.46M | -184.6% | — | 7.5% | |
| LTM Sep 2026 | -$94.49M | -265.1% | — | 15.2% | |
| Peer median (excluding AZTA) | $328.77M | +3.2% | -2.0% | 19.9% | |
Competitors are the stored peer set for AZTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 | FY2026 Sep 2026 |
|---|---|---|---|---|---|
| Revenue | 555.5M | 665.07M | 573.45M | 593.82M | 621.7M |
| Cost of Revenue | 324.88M | 431.82M | 318.83M | 323.54M | 346.74M |
| Gross Profit | 230.62M | 233.26M | 254.62M | 270.28M | 274.96M |
| Gross Margin | 41.5% | 35.1% | 44.4% | 45.5% | 44.2% |
| Research & Development | 27.54M | 33.96M | 31.52M | 30.39M | 37.92M |
| Selling, General & Admin | 227.1M | 281.5M | 253.08M | 251.16M | 257.53M |
| Operating Expenses | 254.64M | 315.45M | 284.6M | 281.55M | 449.66M |
| Depreciation & Amortization | 53.7M | 85.58M | 90.74M | 61.21M | 0 |
| EBITDA | 48.36M | 55.15M | 71.62M | 54.07M | (151.01M) |
| EBITDA Margin | 8.7% | 8.3% | 12.5% | 9.1% | -24.3% |
| Operating Income | (24.02M) | (82.2M) | (29.98M) | (11.27M) | (174.7M) |
| Operating Margin | -4.3% | -12.4% | -5.2% | -1.9% | -28.1% |
| Interest Income | 20.29M | 43.74M | 33.18M | 18.78M | 17.83M |
| Interest Expense | 4.59M | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 14.09M | 51.77M | 10.86M | 4.13M | 23.69M |
| Income Before Tax | (9.94M) | (30.43M) | (19.13M) | (7.14M) | (151.01M) |
| Pre-Tax Margin | -1.8% | -4.6% | -3.3% | -1.2% | -24.3% |
| Income Tax Expense | 1.35M | (17.55M) | 5.24M | (31.6M) | 6.86M |
| Net Income | (428.96M) | (14.26M) | (164.9M) | (55.76M) | (166.99M) |
| Net Margin | -77.2% | -2.1% | -28.8% | -9.4% | -26.9% |
| EPS (Basic) | (0.15) | (0.22) | (3.09) | (1.22) | (3.70) |
| EPS (Diluted) | (0.15) | (0.22) | (3.09) | (1.22) | (3.70) |
| Weighted Avg Shares | 74.9M | 66.25M | 53.18M | 45.74M | 45.13M |
| Weighted Avg Shares (Diluted) | 74.9M | 66.25M | 53.18M | 45.9M | 45.13M |
Azenta, Inc.
NASDAQ:AZTA
Intrinsic Alpha fair value
Locked
Current Price
$48.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.